Found: 119
Select item for more details and to access through your institution.
Multicentric <sup>68</sup>Ga-PSMA PET radiomics for treatment response assessment of <sup>177</sup>Lu-PSMA-617 radioligand therapy in patients with metastatic castrationresistant prostate cancer.
- Published in:
- Frontiers in Nuclear Medicine, 2024, p. 1, doi. 10.3389/fnume.2023.1234853
- By:
- Publication type:
- Article
Key learnings from concordant systematic biopsies in prostate‐specific membrane antigen positron emission tomography/computed tomography‐guided prostate biopsies: Enhancing targeting accuracy.
- Published in:
- Prostate, 2024, v. 84, n. 8, p. 772, doi. 10.1002/pros.24694
- By:
- Publication type:
- Article
Discovering single cannabidiol or synergistic antitumor effects of cannabidiol and cytokine-induced killer cells on non-small cell lung cancer cells.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1268652
- By:
- Publication type:
- Article
Expression of the microtubule-associated protein 2 (MAP2) as a potential independent prognostic marker in prostate cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2024, v. 150, n. 2, p. 1, doi. 10.1007/s00432-023-05579-0
- By:
- Publication type:
- Article
<sup>177</sup>Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer and Prior <sup>223</sup>Ra (RALU Study).
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1925, doi. 10.2967/jnumed.123.266125
- By:
- Publication type:
- Article
High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with 18 F-DCFPyL.
- Published in:
- Molecular Imaging, 2023, p. 1, doi. 10.1155/2022/7056983
- By:
- Publication type:
- Article
Study Protocol of a Prospective, Monocentric, Single-Arm Study Investigating the Safety and Efficacy of Local Ablation of Symptomatic Uterine Fibroids with US-Guided High-Intensity Focused Ultrasound (HIFU).
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 18, p. 5926, doi. 10.3390/jcm12185926
- By:
- Publication type:
- Article
Test–retest repeatability of organ uptake on PSMA‐targeted <sup>18</sup>F‐DCFPyL PET/CT in patients with prostate cancer.
- Published in:
- Prostate, 2023, v. 83, n. 12, p. 1186, doi. 10.1002/pros.24577
- By:
- Publication type:
- Article
Computational analysis of heat shock proteins and ferroptosis-associated lncRNAs to predict prognosis in acutemyeloid leukemia patients.
- Published in:
- Frontiers in Genetics, 2023, p. 01, doi. 10.3389/fgene.2023.1218276
- By:
- Publication type:
- Article
Cytokine-Induced Killer Cells in Combination with Heat Shock Protein 90 Inhibitors Functioning via the Fas/FasL Axis Provides Rationale for a Potential Clinical Benefit in Burkitt's lymphoma.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 15, p. 12476, doi. 10.3390/ijms241512476
- By:
- Publication type:
- Article
Lack of repeatability of radiomic features derived from PET scans: Results from a <sup>18</sup>F‐DCFPyL test–retest cohort.
- Published in:
- Prostate, 2023, v. 83, n. 6, p. 547, doi. 10.1002/pros.24483
- By:
- Publication type:
- Article
Diagnostik und Stadieneinteilung beim metastasierten hormonsensitiven Prostatakarzinom.
- Published in:
- Die Urologie, 2023, v. 62, n. 4, p. 347, doi. 10.1007/s00120-023-02028-1
- By:
- Publication type:
- Article
Safety and Survival Outcomes of <sup>177</sup>Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer with Prior <sup>223</sup>Ra treatment: The RALU Study.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 4, p. 574, doi. 10.2967/jnumed.122.264456
- By:
- Publication type:
- Article
The diagnostic value of ictal SPECT—A retrospective, semiquantitative monocenter study.
- Published in:
- Epilepsia Open, 2023, v. 8, n. 1, p. 183, doi. 10.1002/epi4.12694
- By:
- Publication type:
- Article
Deep learning enables automated MRI-based estimation of uterine volume also in patients with uterine fibroids undergoing high-intensity focused ultrasound therapy.
- Published in:
- Insights into Imaging, 2023, v. 14, n. 1, p. 1, doi. 10.1186/s13244-022-01342-0
- By:
- Publication type:
- Article
Improvement of fibroid-associated symptoms and quality of life after US-guided high-intensity focused ultrasound (HIFU) of uterine fibroids.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-24994-w
- By:
- Publication type:
- Article
Multidisciplinary Postoperative Validation of 18 F-FDG PET/CT Scan in Nodal Staging of Resected Non-Small Cell Lung Cancer.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 23, p. 7215, doi. 10.3390/jcm11237215
- By:
- Publication type:
- Article
mCRPC patients with PSA fluctuations under radioligand therapy have comparable survival benefits relative to patients with sustained PSA decrease.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 13, p. 4727, doi. 10.1007/s00259-022-05910-w
- By:
- Publication type:
- Article
Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy.
- Published in:
- Prostate, 2022, v. 82, n. 14, p. 1406, doi. 10.1002/pros.24414
- By:
- Publication type:
- Article
Matched-pair analysis of [<sup>177</sup>Lu]Lu-PSMA I&T and [<sup>177</sup>Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 9, p. 3269, doi. 10.1007/s00259-022-05744-6
- By:
- Publication type:
- Article
A Combination of Cytokine-Induced Killer Cells With PD-1 Blockade and ALK Inhibitor Showed Substantial Intrinsic Variability Across Non-Small Cell Lung Cancer Cell Lines.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.713476
- By:
- Publication type:
- Article
A Novel Radiomics-Based Tumor Volume Segmentation Algorithm for Lung Tumors in FDG-PET/CT after 3D Motion Correction—A Technical Feasibility and Stability Study.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 3, p. 576, doi. 10.3390/diagnostics12030576
- By:
- Publication type:
- Article
High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with 18 F-DCFPyL.
- Published in:
- Molecular Imaging, 2022, p. 1, doi. 10.1155/2022/7056983
- By:
- Publication type:
- Article
Expanding Theranostic Radiopharmaceuticals for Tumor Diagnosis and Therapy.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 1, p. 13, doi. 10.3390/ph15010013
- By:
- Publication type:
- Article
Interdisziplinärer Expertenkonsensus zu Innovationen der bildgebenden Diagnostik und radionuklidbasierten Therapien des fortgeschrittenen Prostatakarzinoms.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Brief communication: Lutetium-177–prostate-specific membrane antigen ligand following radium-223 treatment in men with bone-metastatic castration-resistant prostate cancer: real-world clinical experience.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262240
- By:
- Publication type:
- Article
Lutetium-177–prostate-specific membrane antigen ligand following radium-223 treatment in men with bone-metastatic castration-resistant prostate cancer: real-world clinical experience.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262240
- By:
- Publication type:
- Article
Lutetium-177–prostate-specific membrane antigen ligand following radium-223 treatment in men with bone-metastatic castration-resistant prostate cancer: real-world clinical experience.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262240
- By:
- Publication type:
- Article
NKG2D Engagement Alone Is Sufficient to Activate Cytokine-Induced Killer Cells While 2B4 Only Provides Limited Coactivation.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.731767
- By:
- Publication type:
- Article
Lutetium-177–prostate-specific membrane antigen ligand following radium-223 treatment in men with bone-metastatic castration-resistant prostate cancer: real-world clinical experience.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262240
- By:
- Publication type:
- Article
Radiolabeling Strategies of Nanobodies for Imaging Applications.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 9, p. 1530, doi. 10.3390/diagnostics11091530
- By:
- Publication type:
- Article
Evaluating a Machine Learning Tool for the Classification of Pathological Uptake in Whole-Body PSMA-PET-CT Scans.
- Published in:
- Tomography: A Journal for Imaging Research, 2021, v. 7, n. 3, p. 301, doi. 10.3390/tomography7030027
- By:
- Publication type:
- Article
Lutetium-177-prostate-specific membrane antigen ligand following radium-223 treatment in men with bone-metastatic castration-resistant prostate cancer: real-world clinical experience.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.262240
- By:
- Publication type:
- Article
Lutetium-177-prostate-specific membrane antigen ligand following radium-223 treatment in men with bone-metastatic castration-resistant prostate cancer: real-world clinical experience.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.121.262240
- By:
- Publication type:
- Article
Lutetium-177--prostate-specific membrane antigen ligand following radium-223 treatment in men with bone-metastatic castration-resistant prostate cancer: real-world clinical experience.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.121.262240
- By:
- Publication type:
- Article
Estimating the Potential of Radiomics Features and Radiomics Signature from Pretherapeutic PSMA-PET-CT Scans and Clinical Data for Prediction of Overall Survival When Treated with 177 Lu-PSMA.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 2, p. 186, doi. 10.3390/diagnostics11020186
- By:
- Publication type:
- Article
Integrative analysis of key candidate genes and signaling pathways in autoimmune thyroid dysfunction related to anti-CTLA-4 therapy by bioinformatics.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 6, p. 1717, doi. 10.1007/s10637-020-00952-z
- By:
- Publication type:
- Article
Immune checkpoint imaging in oncology - a game changer towards personalized immunotherapy?
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.237891
- By:
- Publication type:
- Article
Immune checkpoint imaging in oncology - a game changer towards personalized immunotherapy? Checkpoint imaging in oncology.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.237891
- By:
- Publication type:
- Article
Immune checkpoint imaging in oncology – a game changer towards personalized immunotherapy?
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.237891
- By:
- Publication type:
- Article
Machine Learning Facilitates Hotspot Classification in PSMA-PET/CT with Nuclear Medicine Specialist Accuracy.
- Published in:
- Diagnostics (2075-4418), 2020, v. 10, n. 9, p. 622, doi. 10.3390/diagnostics10090622
- By:
- Publication type:
- Article
Immune checkpoint imaging in oncology – a game changer towards personalized immunotherapy?
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.237891
- By:
- Publication type:
- Article
Immune checkpoint imaging in oncology – a game changer towards personalized immunotherapy?
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.237891
- By:
- Publication type:
- Article
Immune checkpoint imaging in oncology - a game changer towards personalized immunotherapy?
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.237891
- By:
- Publication type:
- Article
DOTA-ZOL: A Promising Tool in Diagnosis and Palliative Therapy of Bone Metastasis—Challenges and Critical Points in Implementation into Clinical Routine.
- Published in:
- Molecules, 2020, v. 25, n. 13, p. 2988, doi. 10.3390/molecules25132988
- By:
- Publication type:
- Article
Immune checkpoint imaging in oncology – a game changer towards personalized immunotherapy?
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.237891
- By:
- Publication type:
- Article
Immune checkpoint imaging in oncology - a game changer towards personalized immunotherapy?
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.237891
- By:
- Publication type:
- Article
Manual vs automated <sup>68</sup>Ga‐radiolabelling—A comparison of optimized processes.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2020, v. 63, n. 4, p. 162, doi. 10.1002/jlcr.3821
- By:
- Publication type:
- Article
Immune checkpoint imaging in oncology - a game changer towards personalized immunotherapy?
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 4, p. 1, doi. 10.2967/jnumed.119.237891
- By:
- Publication type:
- Article
Immune checkpoint imaging in oncology – a game changer towards personalized immunotherapy?
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 3, p. 1, doi. 10.2967/jnumed.119.237891
- By:
- Publication type:
- Article